Trademark: 97936688
Word
MY NAVCARE BY GENMAB
Status Date
Tuesday, March 19, 2024
Filing Date
Monday, May 15, 2023
Published for Opposition
Tuesday, March 19, 2024
41 Educational services, namely, conducting educational programs regarding patient support programs and financial assistance for healthcare; Educational services, namely providing courses of instruction in the field of disease management and navigation through medical treatments; providing online publications, namely non-downloadable brochures, written articles and guidebooks in the field of medical information and patient support in connection with patient reimbursement and patient financial assistance programs; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries
36 Financial administration of patient reimbursement and patient financial assistance programs, namely reimbursement payment processing in the field of pharmaceutical and medical claims; Charitable services, namely, providing financial support to disadvantaged patients for the purpose of reimbursing medical and pharmaceutical expenses; Providing counseling and consulting in the field of healthcare insurance benefits in connection with patient reimbursement and patient financial assistance programs; Providing information about healthcare insurance plans, patient financial assistance, and patient reimbursement programs; Healthcare insurance services, namely, insurance eligibility review and verification, consultation and information in connection with patient reimbursement and patient financial assistance programs; Providing a database featuring information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical treatments; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiarie
35 Business administration of patient reimbursement programs; Business administration of medication reimbursement programs and patient support programs; Provision of consumer information in the field of patient reimbursement and medical benefit support; Business administrative services for medical referrals in connection to patient reimbursement programs; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries
45 Providing personal support services for patients and families of patients in connection to disease management and navigation through medical treatments, namely, emotional counseling and emotional support; Providing personal support services for families of patients with life threatening disorders in connection to disease management and reimbursement of medical expenses, namely, companionship, help with medical forms, emotional counseling and emotional support; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries
44 Medical assistance, namely disease management programs; provision of health care information in connection to disease management and navigation through medical treatments; provision of medical information in connection with health conditions and treatment of these conditions; medical counseling for patients in connection with disease management; Consultancy in the field of the medical treatment of cancer, autoimmune diseases, and inflammatory disorders; providing information to patients and families of patients in the field of administering medication and choosing treatments; providing a website featuring information in the medical and health fields in connection to disease management and navigation through medical treatments; health care services, namely disease management programs; medical and pharmaceutical consultation in connection to disease management; medical services, namely, provision of medical information for supporting patients in relation to the reimbursement of medical expenses; Providing a web site featuring medical information for patients in relation to the reimbursement of medical expenses; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries
The mark consists of the words "MyNavCare," with the word "My" in orange, and the words "NavCare" in green over the words "BY GENMAB" in grey; a stylized star in orange is positioned at the top of the letter "N" in "NavCare."
The color(s) Orange, green and grey is/are claimed as a feature of the mark.
Mar 19, 2024
Official Gazette Publication Confirmation E-Mailed
Mar 19, 2024
Published For Opposition
Feb 28, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 28, 2024
Notification Of Notice Of Publication E-Mailed
Feb 14, 2024
Approved For Pub - Principal Register
Jan 31, 2024
Teas/Email Correspondence Entered
Jan 30, 2024
Correspondence Received In Law Office
Jan 30, 2024
Teas Response To Office Action Received
Jan 23, 2024
Notification Of Non-Final Action E-Mailed
Jan 23, 2024
Non-Final Action E-Mailed
Jan 23, 2024
Non-Final Action Written
Jan 17, 2024
Teas/Email Correspondence Entered
Jan 16, 2024
Correspondence Received In Law Office
Jan 16, 2024
Teas Response To Office Action Received
Jan 15, 2024
Teas Change Of Correspondence Received
Jan 15, 2024
Teas Change Of Domestic Representatives Address
Jan 15, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 15, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 15, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 15, 2024
Teas Change Of Owner Address Received
Oct 17, 2023
Notification Of Non-Final Action E-Mailed
Oct 17, 2023
Non-Final Action E-Mailed
Oct 17, 2023
Non-Final Action Written
Oct 11, 2023
Assigned To Examiner
Sep 13, 2023
Teas Change Of Correspondence Received
Sep 13, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 13, 2023
Teas Change Of Owner Address Received
Jun 14, 2023
Notice Of Design Search Code E-Mailed
Jun 13, 2023
New Application Office Supplied Data Entered
May 18, 2023
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
